• Something wrong with this record ?

Neurotransplantation therapy

J. Cendelin, H. Mitoma,

. 2018 ; 155 (-) : 379-391.

Language English Country Netherlands

Document type Journal Article, Review

Neurotransplantation may be a promising approach for therapy of cerebellar diseases characterized by a substantial loss of neurons. Neurotransplantation could rescue neurons from degeneration and maintain cerebellar reserve, facilitate cerebellar compensation, or help reconstruct damaged neural circuits by cell substitution. These mechanisms of action can be of varying importance according to the type of cerebellar disease. Neurotransplantation therapy in cerebellar ataxias is still at the stage of experimental studies. There is currently little knowledge regarding cerebellar patients. Nevertheless, data provided by experiments in animal models of cerebellar degeneration and both clinical studies and experiences in patients with other neurologic diseases enable us to suggest basic principles, expectations, limitations, and future directions of neurotransplantation therapy for cerebellar diseases.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000651
003      
CZ-PrNML
005      
20190111163142.0
007      
ta
008      
190107s2018 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/B978-0-444-64189-2.00025-1 $2 doi
035    __
$a (PubMed)29891073
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Cendelin, Jan $u Department of Pathological Physiology and Laboratory of Neurodegenerative Disorders, Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czech Republic. Electronic address: jan.cendelin@lfp.cuni.cz.
245    10
$a Neurotransplantation therapy / $c J. Cendelin, H. Mitoma,
520    9_
$a Neurotransplantation may be a promising approach for therapy of cerebellar diseases characterized by a substantial loss of neurons. Neurotransplantation could rescue neurons from degeneration and maintain cerebellar reserve, facilitate cerebellar compensation, or help reconstruct damaged neural circuits by cell substitution. These mechanisms of action can be of varying importance according to the type of cerebellar disease. Neurotransplantation therapy in cerebellar ataxias is still at the stage of experimental studies. There is currently little knowledge regarding cerebellar patients. Nevertheless, data provided by experiments in animal models of cerebellar degeneration and both clinical studies and experiences in patients with other neurologic diseases enable us to suggest basic principles, expectations, limitations, and future directions of neurotransplantation therapy for cerebellar diseases.
650    _2
$a zvířata $7 D000818
650    _2
$a transplantace mozkové tkáně $x metody $7 D016380
650    _2
$a cerebelární ataxie $x chirurgie $7 D002524
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Mitoma, Hiroshi $u Department of Medical Education, Tokyo Medical University, Tokyo, Japan.
773    0_
$w MED00191576 $t Handbook of clinical neurology $x 0072-9752 $g Roč. 155, č. - (2018), s. 379-391
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29891073 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190111163347 $b ABA008
999    __
$a ok $b bmc $g 1364690 $s 1038774
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 155 $c - $d 379-391 $i 0072-9752 $m Handbook of Clinical Neurology $n Handb Clin Neurol $x MED00191576
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...